Summary of Product Characteristics
last updated on the eMC:
29/11/2011
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 29/11/2011 and displayed until Current
|
Reasons for adding or updating:
|
-
Change to section 10 date of revision of the text
|
| Date of revision of text on the SPC: 19-Nov-2010 |
| Legal Category: POM |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| The section 10: Date of Revision of Text is incorrect. The correct date is 19 November 2009.
|
|
Updated on 13/04/2010 and displayed until 29/11/2011
|
Reasons for adding or updating:
|
-
Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
|
| Date of revision of text on the SPC: 01-Aug-2009 |
| Legal Category: POM |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| In section 4.5 (interactions), ciclosporin, methenamine, lithium and sodium bicarbonate interactions have been added to the Diamox SPC
|
|
Updated on 01/09/2009 and displayed until 13/04/2010
|
Reasons for adding or updating:
|
-
New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC
|
| Date of revision of text on the SPC: |
| Legal Category: POM |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| None provided |
|
